NO981057L - Fremgangsmåte for diagnose av cöliaki - Google Patents

Fremgangsmåte for diagnose av cöliaki

Info

Publication number
NO981057L
NO981057L NO981057A NO981057A NO981057L NO 981057 L NO981057 L NO 981057L NO 981057 A NO981057 A NO 981057A NO 981057 A NO981057 A NO 981057A NO 981057 L NO981057 L NO 981057L
Authority
NO
Norway
Prior art keywords
cells
antibody
celiac disease
cell line
condition
Prior art date
Application number
NO981057A
Other languages
English (en)
Other versions
NO981057D0 (no
Inventor
Donald George Weir
Christopher Alexander Whelan
Original Assignee
Trinity College Dublin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Trinity College Dublin filed Critical Trinity College Dublin
Publication of NO981057D0 publication Critical patent/NO981057D0/no
Publication of NO981057L publication Critical patent/NO981057L/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Fremgangsmåte for diagnostisering av cøliaki sykdom og beslektede tilstander hos et individ kjent for eller mistenkt for å ha en slik tilstand, som omfatter å bringe en kroppsvæske fra individet inneholdende antistoff spesielt for tilstanden, i kontakt med en suspensjon av celler fra en udødelig cellelinje med et epitopsete spesifikt for antistoffet, og deretter bestemme graden av binding av antistoff til cellene. Humane navlestrengceller er blitt funnet å være spesielt egnet for anvendelse i denne frem- gangsmåte. Anvendelse av en cellelinje betyr at vesentlige mengder av materialet for antistoff- estimeringen kan fremstilles ved dyrking av cellene og lagring av dem for fremtidig anvendelse med svært lav kostnad.
NO981057A 1995-09-15 1998-03-10 Fremgangsmåte for diagnose av cöliaki NO981057L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IE950725 1995-09-15
PCT/IE1996/000061 WO1997010508A1 (en) 1995-09-15 1996-09-13 Method for the diagnosis of coeliac disease

Publications (2)

Publication Number Publication Date
NO981057D0 NO981057D0 (no) 1998-03-10
NO981057L true NO981057L (no) 1998-03-10

Family

ID=11040894

Family Applications (1)

Application Number Title Priority Date Filing Date
NO981057A NO981057L (no) 1995-09-15 1998-03-10 Fremgangsmåte for diagnose av cöliaki

Country Status (7)

Country Link
EP (1) EP0850418A1 (no)
JP (1) JPH11511559A (no)
AU (1) AU707114B2 (no)
CA (1) CA2231528A1 (no)
NO (1) NO981057L (no)
NZ (1) NZ319260A (no)
WO (1) WO1997010508A1 (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6703208B1 (en) 1999-10-20 2004-03-09 Immco Diagnostics Immunological assay for detection of antibodies in celiac disease
ITRM20020144A1 (it) * 2002-03-15 2003-09-15 Dipartimento Di Scienze Biomed Metodo sierologico per rivelare l'atrofia dei villi intestinali in pazienti affetti da malattia celiaca.
ES2217931B1 (es) * 2002-07-01 2006-02-16 Universidad De Barcelona Metodo de diagnostico de la evolucion de la masa intestinal absortiva en un individuo.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL155894B1 (en) * 1987-12-23 1992-01-31 Przed Zagraniczne W Polsce Pla Test for assessing gluten-dependent enteropathies

Also Published As

Publication number Publication date
NO981057D0 (no) 1998-03-10
AU707114B2 (en) 1999-07-01
WO1997010508A1 (en) 1997-03-20
EP0850418A1 (en) 1998-07-01
JPH11511559A (ja) 1999-10-05
CA2231528A1 (en) 1997-03-20
AU7143996A (en) 1997-04-01
NZ319260A (en) 1999-08-30

Similar Documents

Publication Publication Date Title
Goulding et al. Role of H5 domain in determining pore diameter and ion permeation through cyclic nucleotide-gated channels
Pull et al. Soybean lines lacking the 120,000-dalton seed lectin
Joplin et al. Membrane dihydrolipoamide acetyltransferase (E2) on human biliary epithelial cells in primary biliary cirrhosis
Kiamanesh et al. The state of the heart biopsy: a clinical review
WO2008044032A3 (en) T cell epitope databases
UVELIUS et al. Relation between cell length and force production in urinary bladder smooth muscle
Boldrin et al. Human satellite cells: identification on human muscle fibres
BR9915055A (pt) Teste diagnóstico de tuberculose
DE69821246D1 (de) Testverfahren für collagenpeptid
KR970011852A (ko) 자가면역 질환의 진단 방법
NO981057L (no) Fremgangsmåte for diagnose av cöliaki
Gomollon et al. Breath test is very reliable for diagnosis of Helicobacter pylori infection in real clinical practice
Ramirez-Zarzosa et al. The larval development of lateral musculature in gilthead sea bream Sparus aurata and sea bass Dicentrarchus labrax
Baker et al. Slow virus kidney disease of mice
WO2001002561A3 (en) Mammalian calcium channels and related probes, cell lines and methods
CN104024275A (zh) 对于人β1-肾上腺素受体（β1-AR）的结合化合物以及它们在测量自身抗β1-AR抗体中的应用
BR0209172A (pt) Método de detecção de doenças induzidas por glúten em uma amostra sanguìnea de um indivìduo, e kit teste para uso no método
Ryan Immunofluorescence and immunocytochemistry of endothelial surface antigens
Haanes et al. Sex-biased dispersal in a northern ungulate population
NO881111D0 (no) Fremgangsmaate til isolering av basalmembranproteiner fra menneskelige og dyriske vev.
AU4194897A (en) Immunological composition for detection of bladder cancer and method of using same
Koutsis et al. The afterdepolarization in Rana temporaria muscle fibres following osmotic shock
AU2394597A (en) Oxidative metabolism in smooth muscle cells: methods and materials relating thereto
Kumar Studies of the trunk mechanics during physical activity
ES2719840T3 (es) Método para detectar linfocitos B secretores de anticuerpos específicos para HLA

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application